-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How to Approach Shared Decision Making in Determining Maintenance, Consolidation Therapy and Transplant

Program: Education Program
Session: Acute Myeloid Leukemia - So Many Treatment Options; How Do You Decide?
Monday, December 7, 2020, 6:55 AM-7:00 AM

Alison R. Walker, MD

Division of Hematology, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, OH

Disclosures: Walker: Newave Pharmaceuticals: Research Funding; Geron: Research Funding.